Nutricost Boswellia Extract answers a specific question: how do I get the most genuinely-standardised boswellia for my money? The catch in this category is that cheap usually means unstandardised — most budget boswellia is raw resin the trials never tested. Nutricost is the high-strength exception: it states 65% boswellic acids, delivers 1,200 mg of extract in a two-cap serving that lands squarely in the trial dose window, and ships 180 caps for roughly $15 — the lowest cost-per-gram of standardised extract on the list. You give up AKBA precision (it standardises to total boswellic acids, like NOW) and a clinician-grade presentation, but you keep the thing that matters most — high-strength, real standardisation — at the best price-per-active on the page. Here's the full breakdown.
Check on AmazonAffiliate link — Super Achiever Club earns a small commission at no extra cost to you.
Read the complete Boswellia guide →A high standardisation figure — 65% boswellic acids, roughly 780 mg of acids per 1,200 mg serving — well above the unstandardised resin that fills the budget aisle. It sits in the strong mid tier, trailing the 5-Loxin / AprèsFlex picks only because it standardises to total boswellic acids rather than a stated AKBA %, the same precision gap as NOW.
Reaches the ~1,000 mg/day standardised-extract window (Kimmatkar 2003) in just two caps (1,200 mg) — better than the lower-strength whole extracts that need three. A sensible two-cap serving hits the trial dose cleanly, with room to split morning and evening for steadier levels.
Manufactured in a GMP-compliant facility, labelled non-GMO and gluten-free, and third-party tested — reasonable for the value tier and a step up from unbranded resin. Not positioned as clinician-grade like Pure Encapsulations, but a third-party-tested, GMP-made standardised extract is a sensible quality floor for an adulteration-prone botanical.
The lowest cost-per-gram of standardised extract on the list — roughly $15 for 180 caps, about $0.17 for a 1,200 mg two-cap serving. Because it hits the trial dose in two caps rather than three, the cost-per-productive-dose is exceptional. This is the criterion the whole pick is built around.
A clean single-active standardised extract — no proprietary blend, no junk fillers hiding the dose. It scores solidly but not top, because it adds nothing beyond the extract (no turmeric co-factor like NOW, no hypoallergenic standard like Pure Encapsulations) — which is exactly the trade for the value price.
“Standardised to 65% boswellic acids.”
A genuine, high standardisation figure consistent with Nutricost's published label — roughly 780 mg of boswellic acids per 1,200 mg serving. This is the key claim that earns the bottle its place: high-strength standardised material at a value price, not the unstandardised resin that fills the rest of the budget aisle.
“Supports joint health and a normal inflammatory response.”
Boswellia's joint and anti-inflammatory benefits are backed by real RCTs — Kimmatkar 2003 (PMID 12622457) found a standardised extract reduced knee-OA pain and improved function versus placebo over 8 weeks. A 65%-standardised extract dosed at 1,200 mg/day sits within that evidence base.
“Premium quality at a great value.”
Fair on value, generous on "premium." The extract is genuinely standardised to a high figure and third-party tested, which is real quality at the price — but Nutricost is a value brand, not a clinician-grade marque, and it standardises to total boswellic acids rather than a named AKBA fraction. Excellent value; "premium" overstates the tier.
“Third-party tested for quality and purity.”
Nutricost third-party tests its extracts and manufactures in a GMP-compliant facility — a verifiable, established practice. For a standardised botanical at a value price, third-party testing is a reasonable and real quality floor, well above the unbranded resin alternatives.
What makes Nutricost worth ranking isn't just that it's cheap — it's that it's cheap, high-strength, AND genuinely standardised, a combination the budget aisle almost never offers. Most sub-$15 bottles are unstandardised resin the trials never tested; Nutricost gives you a 65%-standardised extract with roughly 780 mg of boswellic acids per serving, for the lowest cost-per-gram on the list. That's the entire value proposition: you don't have to choose between standardised, strong, and affordable. For a buyer who wants maximum standardised active per dollar, it's the rational pick.
Nutricost's 1,200 mg two-cap serving lands squarely in the ~1,000 mg/day window Kimmatkar 2003 used for a standardised whole extract — and it gets there in two caps, where the lower-strength whole-extract picks (NOW, Swanson) need three. That makes the 180-cap bottle a clean three-month supply at the full dose, and it's a big reason the cost-per-productive-dose is so low. Take two caps with food; split them morning and evening if you want steadier levels through the day.
Nutricost standardises to total boswellic acids (65%), not to a stated AKBA percentage — the same precision limitation as NOW (#1) and the other whole-extract picks. The strongest trial (Sengupta 2008) used 5-Loxin enriched to ~30% AKBA, the most potent fraction, which the pure-play AKBA picks (Life Extension #2) deliver. But for a value bottle whose job is to provide high-strength standardised boswellia at the best price-per-gram, total-boswellic-acid standardisation at 65% is entirely adequate. Chase AKBA precision later with 5-LOXIN if you want it.
Nutricost's manufacturing and testing are reasonable for the price — GMP-compliant facility, non-GMO, gluten-free, third-party tested — but it isn't positioned as a clinician-grade marque like Pure Encapsulations or Life Extension, and the bottle is a no-frills single-active extract: no turmeric co-factor, no hypoallergenic standard, no branded clinical material. That's not a knock; it's the deliberate trade for the best cost-per-gram. The upside is the 180-cap bottle's long runway — roughly three months at the full dose.
Position Nutricost correctly and it's an easy buy: it wins decisively on cost-per-gram of standardised extract, and it's genuinely high-strength at 65% boswellic acids. It doesn't try to win on AKBA enrichment (that's 5-LOXIN #2), a complementary co-factor (NOW #1), or a clinician-grade clean label (Pure Encapsulations #4) — and it shouldn't be bought expecting those. Buy it for exactly what it is: the most standardised boswellia per dollar on the list, in a long-runway bottle from a third-party-tested value brand.
Nutricost Boswellia Extract is the pick for anyone who wants the most genuinely-standardised boswellia for their money. Crucially, it's a high-strength standardised extract — 65% boswellic acids, roughly 780 mg of acids per serving — not the unstandardised resin that dominates the budget aisle, and it hits the trial dose in just two caps. The 180-cap bottle at roughly $15 is the lowest cost-per-gram on the list. You give up AKBA precision (it standardises to total boswellic acids, like NOW) and a clinician-grade presentation, but you keep high-strength, real standardisation at the best price-per-active on the page. Choose differently only if your priority is something other than cost-per-gram: AKBA precision (Life Extension 5-LOXIN #2 uses the named extract the strongest trial used), a hypoallergenic label (Pure Encapsulations #4), or a boswellia-plus-curcumin combo (Terry Naturally Curamin #3). For pure standardised-boswellia-per-dollar value, Nutricost is the clear answer — take two caps with food and give it 2-4 weeks.
Check Nutricost · Boswellia serrata extract, 65% boswellic acids · 180 veg caps on AmazonA standardised whole extract (65% boswellic acids) plus a turmeric co-factor at ~$11/month from a stronger-pedigree brand. The small step up if you want a co-factor and NOW's in-house QC.
See it on the list →The named AKBA-enriched 5-Loxin extract (~30% AKBA) the strongest trial used. The upgrade if you want maximal AKBA precision rather than maximal cost-per-gram value.
See it on the list →A 1,000 mg, 65%-standardised extract in a 240-cap mega-bottle, third-party tested for heavy metals — the bulk refill once you already know boswellia works for you.
See it on the list →Randomised, double-blind, placebo-controlled crossover trial in knee-osteoarthritis patients: a standardised Boswellia serrata extract significantly reduced knee pain, improved function, and increased walking distance versus placebo over 8 weeks. The efficacy and dosing basis (~333 mg three times daily, ~1,000 mg/day) for a standardised extract like Nutricost's.
Placebo-controlled trial of 5-Loxin (an AKBA-enriched Boswellia extract, ~30% AKBA) at 100 and 250 mg/day in knee osteoarthritis: significant, dose-related pain and function improvements, with benefits within ~7 days at 250 mg. Defines the AKBA-enriched precision tier Nutricost's total-boswellic-acid standardisation sits below.
One free quiz · personalized AI Coach path · 4 missions this week. Build your character, build your life.
